Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Enabling a Comeback in Ion Channel Drug Discovery

Sep 01 2003

• By Chris Morrison

Related Content

Millennium's P&L-Based Strategy and the Ortho/J&J Deal

Jul 01 2003

The Re-Emergence of Ion Channel Drug Discovery

May 01 2003

Related Companies

Roche Holding AG

H. Lundbeck A/S

Forest Laboratories, Inc.

Sophion Bioscience AS

NeuroSearch A/S

Cellectricon AB

Aviva Systems Biology Corp.

Danaher Corp.

Nordion

Vertex Pharmaceuticals Incorporated

Bayer AG

Xention Pharma Limited

PAION AG

Ionix Pharmaceuticals Ltd.

Newron Pharmaceuticals S.p.A.

Scion Pharmaceuticals Inc.

Neuromed Pharmaceuticals Ltd.

Sophion Bioscience AS

NeuroSearch A/S

Pfizer Inc.

Cytomyx Holdings PLC

Tripos, Inc.

Xention Pharma Limited

PAION AG

Scion Pharmaceuticals Inc.

GSK plc

Wyeth

Takeda Pharmaceutical Co. Ltd.

Evotec SE

Additional Topics

Europe Strategy Business Strategies BioPharmaceutical

More from Global Vision

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window